• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates
Home » Bankrupt ReGen gets another cash infusion through investor | Funding roundup

Bankrupt ReGen gets another cash infusion through investor | Funding roundup

April 28, 2011 By MassDevice staff

Funding

Bankrupt ReGen Biologics Inc. (OTC:RGBO) took out a loan from a company affiliated with one of its investors. The new debt represents Regen’s second financing deal with the company since filing for Chapter 11 bankruptcy two weeks ago.

Sports Medicine Holding Company LLC — an affiliate of Ivy Healthcare Capital II LP, which is one of ReGen’s secured creditors in addition to one of its largest institutional shareholders — entered a debtor-in-possession financing deal with ReGen through which the orthopedic device maker can borrow up to $1.4 million, according to a Securities & Exchange Commission filing.

Loans taken through the deal, which is still subject to U.S. Bankruptcy Court approval, mature on June 20 and come with an interest rate of 12 percent per year and 18 percent if ReGen defaults. The funds are also secured by "substantially all of" ReGen’s assets, according to the filing.

ReGen has already raised $1 million through a private placement deal with the Sports Medicine Holding Company. The private placement comes in the form of senior secured notes due August 31, which carry a 12 percent annual interest rate.

The bankruptcy filing added yet another layer to the ReGen story, featuring a protracted and public battle with the FDA for nearly two years. Earlier this month, the FDA rescinded its 2008 510(k) clearance of the Menaflex device, a bio-absorbable mesh implant designed to encourage the re-growth of damaged knee cartilage. The rescission means Hackensack, N.J.-based ReGen needs to keep the device off the U.S. market until it can prove its safety and effectiveness to the FDA’s satisfaction.

ReGen wasn’t shy about voicing its displeasure over the rescission, with CEO Gerald Bisbee calling it “totally unbelievable.”

The FDA said it wants ReGen to “discuss the appropriate marketing pathway for the device and what data it would need to provide a reasonable assurance of safety and effectiveness,” five years after the company began the 510(k) application process.

ReGen has sunk $30 million into meeting requirements set by the FDA’s Center for Devices & Radiological Health, according to Bisbee, “only to have the agency reverse decisions made by previous CDRH officials by stating that they were in error with no substantial evidence that is true.”

Here’s a roundup of the latest dealflow and investment news:

  • Interrad Medical attempts to raise $10 million
    Interrad Medical Inc. is aiming to raise $10 million, according to a filing with the Securities & Exchange Commission. The Plymouth, Minn.-based medical device company, which makes a device to secure catheters, has already raised $1.64 million. Last year, the company was looking to raise $6 million and was able to raise nearly $2 million, according to the filing. Interrad’s SecurAcath Universal Subcutaneous Catheter Securement System won a 510(k) clearance in July, writes MedCity News.
    Read more
  • Cianna closes on $12 million in funding
    Cianna Medical, a breast brachytherapy company, announced that it has successfully completed a funding round totaling $12 million. The Series B round was led by an investment of $8 million from Novo Ventures, Novo A/S. Continuing investors participating in this round were Fog City Fund, Emergent Medical Partners, and Saints Capital.
    Read more
  • Meritech Capital drums up $425 million with fourth fund
    Meritech Capital Partners (MCP), a late-stage venture capital firm, announced the closing of Meritech Capital Partners IV, a $425 million late-stage venture capital fund. The fund will continue MCP’s successful strategy of investing in rapidly-growing technology companies primarily in the United States. This fund brings the firm’s cumulative capital under management to $2.6 billion. With MCP IV, the firm will primarily target four sectors: Internet and Digital Media, Communications and Wireless, Enterprise IT and Medical Devices.
    Read more
  • Gates Foundation grants another $100,000 for global health ideas
    The Gates Foundation announced its latest set of grants from its Grand Challenges Exploration program, saying that it has found some high-growth prospects in vaccines, drugs and diagnostics. The foundation has already given 88 scientific teams from around the world $100,000 awards to test some "out-of-the-box" ideas that are too daring to get support from federal funding agencies, writes Xconomy.
    Read more
  • Gene Security Network lands $2 million from NIH
    Gene Security Network (GSN) announced that they have received a $2 million grant from the National Institutes of Health (NIH) to conduct a clinical trial applying Parental Support technology for non-invasive prenatal diagnosis (NIPD). NIPD will enable highly accurate detection of severe fetal genetic abnormalities by testing fetal DNA found in maternal blood.
    Read more
  • USC and Coulter Foundation invest $5 million
    The USC Viterbi School of Engineering, Keck School of Medicine of USC, the USC Stevens Institute for Innovation, and the Los Angeles Basin Clinical Translational Science Institute (CTSI) have been selected to participate in the exclusive Coulter Translational Research Partnership Program. The program awards pioneering institutions that are fostering tomorrow’s translational technologies and innovations in biomedical health care. For its operations, the Program will have $1 million each year for a period of five years, with $667,000 a year from the Coulter Foundation augmented by $333,000 of contributions from the USC Viterbi School of Engineering, the CTSI, and the USC Stevens Institute for Innovation.
    Read more
  • Oxford Nanopore drums up $41 million
    Illumina Inc. (NSDQ:ILMN) made another equity investment in Oxford Nanpore. Oxford raised $41 million (25 million pounds) from Lansdowne Partners, IP Group, Invesco Perpetual, Redmile Group, Illumina and other investors, according to a statement from the company. Illumina first invested in Oxford, and its method for DNA sequencing, in January 2009, and made another investment in February 2010, according to Xconomy.
    Read more
  • Hospira readies $1 billion share buyback
    Hospira Inc. (NYSE:HSP) announced that its board of directors has authorized the repurchase of up to $1 billion of the company’s common stock. The multi-year program authorizes the company to repurchase common shares from time to time through the open market and through private transactions in compliance with securities regulations and other legal requirements. The size and timing of any purchases are at the discretion of company management, based on factors such as price, business and market conditions. The program does not have an expiration date.
    Read more
  • Solta Medical extends loan deal
    Solta Medical Inc. entered into the Fifth Amendment to its Loan and Security Agreement with Silicon Valley Bank dated as of March 9, 2009, as amended from time to time. The Amendment provides for an extension of the draw period of the additional term loan facility such that terms loans under the facility may be borrowed until March 31, 2012 and will be repaid in 33 equal monthly payments of principal and interest, but no later than Dec. 31, 2014.
    Read more
  • CareView Communications secures $20 million
    CareView Communications Inc. (OTC:CRVW), an information technology provider to the healthcare industry, announced that it has closed a $20 million financing with funds managed by HealthCor Partners Management LP and HealthCor Management, LP. The financing involved the issuance of senior secured convertible notes in the aggregate principal amount of $20 million together with common stock purchase warrants. HealthCor is a leading investment manager in the healthcare and life sciences sectors.
    Read more
  • Photologic goes into liquidation
    Photologic has gone into liquidation after almost 20 years in business. The Photologic Dublin, Ireland-based medical imaging company employed about 40 people and had sales of over €20 million in 2009, according to its latest accounts. Photologic was owned by John Gallagher, the founder of the Charter Medical Group, reports Post.IE.
    Read more

Filed Under: News Well Tagged With: Bankruptcy, Bill & Melinda Gates Foundation, CareView Communications Inc., Cianna Medical, Gene Security Network, Hospira Inc., Illumina Inc., Interrad Medical Inc., Meritech Capital Partners, ReGen Biologics Inc., Solta Medical Inc., Venture Capital/Private Equity

In case you missed it

  • Orchestra BioMed to go public, partner with Medtronic on cardiac neuromodulation therapy
  • Memic Innovative Surgery is now Momentis Surgical
  • Lyra Therapeutics appoints new chief medical officer
  • Masimo’s SafetyNet monitoring reduced length of COVID-19 hospital stays, study says
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • Enovis partners with Kelvi on hot and cold therapies
  • West Pharmaceutical Services debuts new needle syringe system
  • Titan Medical names Cary G. Vance as new president, CEO
  • Acutus completes first closing in left-heart access portfolio sale to Medtronic
  • FDA clears Intuitive, Siemens Healthineers imaging integration for robotic bronchoscopy
  • FDA backs COVID-19 boosters with BA.4/5 spike proteins for fall
  • How safe is health information after the overturning of Roe?
  • Smith+Nephew opens new plant in Malaysia
  • BD launches combination COVID-19, flu, RSV diagnostic test
  • Zimmer Biomet creates independent nonprofit organization to reduce health disparities
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

RSS From Medical Design & Outsourcing

  • DeviceTalks Boston 2022: Here’s what you missed on the show floor
    At DeviceTalks Boston 2022, there was a wealth of expertise to be had from exhibitors including Viant, ICS, PSN Labs, Propel and more. From stories of overcoming challenges during the COVID-19 pandemic to medical device materials pitfalls to avoid, MassDevice and MDO executive editor Chris Newmarker hit the DeviceTalks Boston show floor to discover insights. […]
  • Supply Chain EVP Greg Smith sees fewer suppliers in Medtronic’s future
    All eyes are on Medtronic’s global operations and supply chain leader as he works to modernize its operations and scrutinize suppliers. EVP of Global Operations and Supply Chain Greg Smith anticipates fewer suppliers in Medtronic’s future, he said in an interview this week. Smith spoke with DeviceTalks Editorial Director Tom Salemi in his first published… […]
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
    CeQur designed its Simplicity device to make insulin delivery as seamless as possible for people with diabetes. When it comes to managing diabetes, CeQur wants to make insulin therapy as convenient as possible. For those who prefer to manage their own insulin delivery, the Simplicity device might just do exactly that. Simplicity, a wearable, disposable… […]
  • Meddux opens new facility in Colorado
    Engineering, design, development and manufacturing company Meddux announced that it opened a new facility in Boulder, Colorado. The new, 22,000-square-foot facility doubles the overall square footage from its previous location in Colorado. According to a news release, it helps the company to quadruple its product development area and double its manufacturing footprint. Meddux’s new facility… […]
  • Reducing the Overall Cost of Validation
    By PTI Engineered Plastics Reliable medical devices and equipment are essential for researchers and doctors to accurately diagnose and treat a wide range of diseases. That is why there is such stringent oversight from the FDA to ensure these products meet the necessary requirements and specifications. To ensure compliance with regulators, manufacturers follow installation qualification… […]
  • BBS Automation has a deal to buy medtech supplier Kahle Automation
    BBS Automation said it plans to purchase high-speed automation supplier Kahle Automation to expand its medtech and life sciences business. Kahle will operate as Kahle – a BBS Company, according to a news release from Munich, Germany-based BBS and Lombardy, Italy-based Kahle. The deal is subject to regulatory approval. Terms were not disclosed. Kahle’s co-owners —… […]
  • How safe is health information after the overturning of Roe?
    The U.S. Department of Health and Human Services today issued guidance meant to better protect women’s health information as state abortion bans kick in after the U.S. Supreme Court’s overturning of Roe v. Wade. Despite the HHS actions, women may still wonder whether their health information is entirely safe going forward — a potential challenge… […]
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge
    New evidence is showing that COVID-19 may increase a person’s risk of diabetes, but it could be years until we know for sure. In the meantime, Dexcom (Nasdaq:DXCM) is getting ready, VP of Global Clinical Initiatives Tomas Walker said. Walker recently spoke with Medical Design & Outsourcing to discuss the San Diego-based diabetes device developer’s… […]
  • Blackrock Neurotech and Pitt work on first at-home BCI system for remote trials
    Blackrock Neurotech and the University of Pittsburgh’s Rehab Neural Engineering Labs (Pitt RNEL) are working together on the first portable brain-computer interface (BCI) to allow patients to participate in research trials from home. A Blackrock representative said it’s the final step as the company prepares to launch its first commercial product early next year. Salt… […]
  • How medical device companies are responding to abortion bans
    Days after the U.S. Supreme Court’s decision to overturn Roe v. Wade’s protection of abortion rights, medical device companies are among those reassuring workers about healthcare access. Corporate communications to employees and the public at large come as trigger laws in nearly half of the states outlaw abortion immediately. Some medtech companies are not using… […]
  • Philips updates on testing results for recalled ventilators
    Royal Philips (NYSE:PHG) says only a small portion of returned respiratory devices displayed the sound abatement foam degradation that sparked a massive recall. Repeated ozone cleaning may have made the problem worse. Those were some of the major takeaways from an update Philips provided today on a comprehensive test and research program it implemented after its… […]

Leave a Reply

You must be logged in to post a comment.

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS